Introduction
============

There are more than one billion tobacco users worldwide and 80% of them live in low and middle income countries. As per estimates, 246 million smokers and 290 million smokeless tobacco users in the World Health Organization (WHO) South East Asia Region which makes it one of the largest tobacco consuming regions (World Health Organisation South-East Asia Regional Office (WHO SEARO), 2017). Those numbers are still become a global health problem, because both smoking and smokeless tobacco users have well known increase the risk of death from various diseases such as coronary heart disease, stroke, and respiratory disorders in adults, and many types of cancer which may increase the health burden of nations (World Health Organization (WHO), 2011a)

Smoking increases the risk of malignant tumors in nearly all organs with at least 30% of all cancer deaths smoking is attributed to smoking (Bassiony et al., 2015). Once tobacco has damaged cells, they can grow uncontrollably as cancer. When DNA is damaged, a cell can begin growing out of control and create a cancer tumor. This happens because poisons in tobacco smoke can destroy or change the cell's instructions that might damage DNA in a way that leads to cancer (US Department of Health and Human Services, 2010). The long time lags for development of cancer associated with smoking, the impact of smoking caused diseases on mortality in many regions estimates will continue to rise for at least two decades (World Health Organization (WHO), 2009).

At present, there are 121 million adult smokers, approximately 10% of world's smoker, in member countries of Association of Southeast Asian Nations (ASEAN) countries (Kimman et al., 2015). ASEAN was established on 8 August 1967 and consists of eleven countries namely Brunei Darussalam, Cambodia, Indonesia, Lao PDR, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam, and Timor Leste in South East Asia region. The member countries have a combined population of approximately 625 million people, accounted for 9% of the world's population (Kristina et al., 2016).

South East Asia is one of the world's largest tobacco epidemic regions (Katanoda et al., 2014). Based on Kristina et al., (2016) study, tobacco smoking was responsible for about 131,502 cancer cases (28.4%) and 105,830 cancer deaths (30.5%) in ASEAN 2012 using data from GLOBOCAN 2012. As data from GLOBOCAN 2018 has had released on 12 September 2018 (World Health Organisation (WHO) IARC, 2018), the aim of this study to calculate the estimated burden of several types of cancer due to smoking in ASEAN 2018 and compare it with result data in 2012. So through this study, it can be highlight what has been achieved and what it needs to be addressed by member countries of ASEAN to strengthen cancer prevention against tobacco smoking.

Materials and Methods
=====================

This research was using descriptive epidemiological incidence and prevalence-based research design to estimate the burden of cancer due to smoking in members of ASEAN. There were three steps to gain the data; first we selected smoking-related cancer and estimated population-related smoking attributable fraction (SAF) using relative risks and prevalence of tobacco smokers in each member countries of ASEAN. Second, we find the number of incidence and cancer mortality of each country. Then lastly, we estimated smoking attributable incidence and mortality from the number of incidence and mortality multiply by SAF.

*Smoking prevalence*

The prevalence of current tobacco smokers among individuals aged 15 years and older, published by WHO global report on trends in prevalence of tobacco smoking 2000-2001, was obtained from Kristina et al., (2016) study (Kristina SA et al., 2016). As the burden of cancer observed in 2018 reflects the past exposure of smoking, the prevalence in the year 2000 was used in our study due to long time lags for development of cancer associated with smoking (World Health Organization (WHO), 2009). Timor Leste country prevalence of smoking was not included since the year of 2000's data was not available. As shown in [Table 1](#T1){ref-type="table"}, the highest prevalence of tobacco smoking both among male was in Lao PDR (71.5%), followed by Philippines (59.1%), and Malaysia (56.0%). Meanwhile the highest prevalence of tobacco smoking among female in ASEAN member countries found in Lao PDR (19.9%), Myanmar (14.7%), and the Philippines (11.0%), respectively. Generally, the prevalence of smoker was quite lower in female than in male.

###### 

Prevalence of Tobacco Smoking among ASEAN Countries

  ---------------------------------------------------------------------------
  Country/year        Number of population\   Prevalence of Tobacco\   
                      (million)               smoking                  
  ------------------- ----------------------- ------------------------ ------
  Brunei/2,000        0.4                     29.4                     4.8

  Cambodia/2,000      14.5                    44.5                     7.1

  Indonesia/2,000     237.7                   54.8                     4.9

  Lao PDR/2,000       6.4                     71.5                     19.9

  Malaysia/2,000      28.9                    56                       3

  Myanmar/2,000       60.4                    55.2                     14.7

  Philippines/2,000   95.8                    59.1                     11

  Singapore/2,001     3.8                     24.2                     3.5

  Thailand/2,000      67.6                    46.8                     2.9

  Viet Nam/2,000      87.8                    49.4                     1.6
  ---------------------------------------------------------------------------

Source, Kristina et al., (2016)

###### 

Relative Risks and Smoking Attributable Fractions (SAFs) of Selected Cancer in ASEAN Countries

  Gender   Cancer             RR     SAF                                                            
  -------- ------------------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------
  Male     Lip, oral cavity   3.43   0.42   0.52   0.57   0.63   0.58   0.57   0.59   0.37   0.53   0.54
           Nasopharynx        1.95   0.22   0.3    0.34   0.4    0.35   0.34   0.36   0.19   0.31   0.31
           Pharynx            6.76   0.63   0.72   0.76   0.8    0.76   0.76   0.77   0.58   0.73   0.74
           Esophagus          2.5    0.31   0.4    0.45   0.52   0.46   0.45   0.47   0.27   0.41   0.42
           Stomach            1.74   0.18   0.25   0.29   0.35   0.29   0.29   0.3    0.15   0.26   0.26
           Colorectal         1.13   0.04   0.05   0.07   0.09   0.07   0.07   0.07   0.03   0.06   0.06
           Liver              1.56   0.14   0.2    0.23   0.29   0.24   0.24   0.25   0.12   0.21   0.21
           Pancreas           1.7    0.17   0.24   0.28   0.33   0.28   0.28   0.29   0.14   0.25   0.25
           Larynx             6.98   0.64   0.73   0.77   0.81   0.77   0.77   0.78   0.59   0.74   0.74
           Lung               8.96   0.7    0.78   0.81   0.85   0.82   0.81   0.82   0.66   0.79   0.79
           Cervix uteri       NA     NA     NA     NA     NA     NA     NA     NA     NA     NA     NA
           Ovary              NA     NA     NA     NA     NA     NA     NA     NA     NA     NA     NA
           Kidney             1.52   0.13   0.19   0.22   0.27   0.23   0.22   0.24   0.11   0.2    0.2
           Bladder            2.77   0.34   0.44   0.49   0.56   0.5    0.49   0.51   0.3    0.45   0.46
  Female   Lip, oral cavity   3.43   0.1    0.15   0.11   0.33   0.07   0.26   0.21   0.08   0.07   0.04
           Nasopharynx        1.95   0.04   0.06   0.04   0.16   0.03   0.12   0.09   0.03   0.03   0.01
           Pharynx            6.76   0.22   0.29   0.22   0.53   0.15   0.46   0.39   0.17   0.14   0.08
           Esophagus          2.5    0.07   0.1    0.07   0.23   0.04   0.18   0.14   0.05   0.04   0.02
           Stomach            1.45   0.02   0.03   0.02   0.08   0.01   0.06   0.05   0.02   0.01   0.01
           Colorectal         1.4    0.02   0.03   0.02   0.07   0.01   0.06   0.04   0.01   0.01   0.01
           Liver              1.56   0.03   0.04   0.03   0.1    0.02   0.08   0.06   0.02   0.02   0.01
           Pancreas           1.7    0.03   0.05   0.03   0.12   0.02   0.09   0.07   0.02   0.02   0.01
           Larynx             6.98   0.22   0.3    0.23   0.54   0.15   0.47   0.4    0.17   0.15   0.09
           Lung               8.96   0.28   0.36   0.28   0.61   0.19   0.54   0.47   0.22   0.19   0.11
           Cervix uteri       1.83   0.04   0.06   0.04   0.14   0.02   0.11   0.08   0.03   0.02   0.01
           Ovary              2.07   0.05   0.07   0.05   0.18   0.03   0.14   0.11   0.04   0.03   0.02
           Kidney             1.52   0.02   0.04   0.02   0.09   0.02   0.07   0.05   0.02   0.01   0.01
           Bladder            2.77   0.08   0.11   0.08   0.26   0.05   0.21   0.16   0.06   0.05   0.03

###### 

Smoking Attributable Cancer Incidence in ASEAN Countries, 2018

  Gender   Cancer             Smoking attributable cancer incidence, 2018   Total                                                                        
  -------- ------------------ --------------------------------------------- ------- -------- ------- ------- -------- -------- ------- -------- -------- ---------
  Male     Lip, oral cavity   0                                             90      1,656    52      148     843      409      41      1,095    639      4,973
           Nasopharynx        6                                             48      4,520    54      535     470      633      75      437      1,309    8,087
           Pharynx            0                                             78      743      47      98      1,207    308      47      894      1,487    4,908
           Esophagus          1                                             76      339      92      111     1,147    314      38      1,007    775      3,901
           Stomach            3                                             50      523      109     189     1,031    404      37      396      2,403    5,146
           Colorectal         3                                             29      1,099    23      176     154      512      42      385      370      2,792
           Liver              4                                             282     2,796    172     289     754      1,424    81      2,752    3,810    12,363
           Pancreas           1                                             14      644      9       118     96       370      50      240      113      1,657
           Larynx             1                                             69      2,056    41      286     798      792      62      771      959      5,835
           Lung               27                                            618     15,599   455     2,339   3,030    8,049    909     8,098    10,891   50,016
           Cervix uteri       NA                                            NA      NA       NA      NA      NA       NA       NA      NA       NA       0
           Ovary              NA                                            NA      NA       NA      NA      NA       NA       NA      NA       NA       0
           Kidney             2                                             12      283      8       103     57       282      74      142      203      1165
           Bladder            2                                             51      2,327    29      230     1,757    405      72      737      404      6014
           Total              50                                            1,419   32,585   1,092   4,621   11,346   13,902   1,528   16,953   23,363   106,858
  Female   Lip, oral cavity   0                                             22      188      19      18      158      100      4       78       16       603
           Nasopharynx        1                                             5       167      13      13      78       76       5       15       21       393
           Pharynx            0                                             10      94       5       8       73       42       3       26       32       293
           Esophagus          0                                             5       15       3       4       127      22       1       16       5        197
           Stomach            0                                             5       13       15      7       140      44       4       18       34       279
           Colorectal         1                                             15      171      21      25      102      220      13      71       35       674
           Liver              0                                             25      83       26      6       118      110      3       82       41       493
           Pancreas           0                                             2       48       3       6       24       74       5       15       4        180
           Larynx             0                                             3       44       4       6       41       54       1       15       17       185
           Lung               10                                            168     1,581    131     188     1,491    1,805    124     1,009    568      7,076
           Cervix uteri       2                                             51      1,201    43      38      680      564      8       183      50       2,819
           Ovary              2                                             25      603      27      37      214      482      13      86       23       1,513
           Kidney             0                                             1       11       2       4       9        30       2       5        8        71
           Bladder            0                                             4       75       3       7       44       50       4       21       6        214
           Total              17                                            341     4,293    313     367     3,299    3,673    189     1,640    860      14,991
  Total                       67                                            1,759   36,877   1,405   4,988   14,644   17,576   1,717   18,593   24,223   121,849

###### 

Smoking Attributable Cancer Mortality ASEAN Countries, 2018

  Gender   Cancer             Smoking attributable cancer mortality, 2018   Total                                                                        
  -------- ------------------ --------------------------------------------- ------- -------- ------- ------- -------- -------- ------- -------- -------- --------
  Male     Lip, oral cavity   0                                             56      761      29      68      480      193      18      571      288      2,463
           Nasopharynx        3                                             39      2,839    40      298     350      402      47      293      857      5,167
           Pharynx            0                                             53      379      27      48      781      158      23      478      778      2,725
           Esophagus          0                                             76      297      86      100     1,125    286      34      894      689      3,586
           Stomach            2                                             40      399      92      136     821      296      32      347      1,854    4,,020
           Colorectal         1                                             17      530      13      79      88       239      20      208      169      1,365
           Liver              3                                             284     2,757    172     286     764      1,408    72      2,770    3,847    12,363
           Pancreas           1                                             15      630      9       113     93       363      42      252      102      1,620
           Larynx             0                                             39      922      22      127     440      366      18      433      425      2,792
           Lung               18                                            599     13,456   438     1,970   2,997    7,204    819     8,037    9,359    44,896
           Cervix uteri       NA                                            NA      NA       NA      NA      NA       NA       NA      NA       NA       0
           Ovary              NA                                            NA      NA       NA      NA      NA       NA       NA      NA       NA       0
           Kidney             1                                             9       153      5       44      33       129      16      82       105      574
           Bladder            0                                             26      955      12      85      126      144      18      372      163      1,902
           Total              29                                            1,251   24,077   945     3,354   8,097    11,188   1,159   14,735   18,637   83,472
  Female   Lip, oral cavity   0                                             12      74       9       7       80       41       2       39       6        271
           Nasopharynx        0                                             3       89       8       7       52       41       2       8        13       224
           Pharynx            0                                             6       38       3       3       46       17       1       12       17       143
           Esophagus          0                                             5       12       3       4       116      19       1       13       4        176
           Stomach            0                                             4       10       13      5       113      33       2       16       26       222
           Colorectal         0                                             9       81       11      11      58       101      6       37       16       331
           Liver              0                                             25      80       25      5       119      107      3       80       41       486
           Pancreas           0                                             2       46       2       5       23       70       5       12       4        170
           Larynx             0                                             2       25       3       3       29       33       0       12       10       117
           Lung               7                                             162     1,283    124     148     1,440    1,473    110     989      462      6,197
           Cervix uteri       1                                             34      628      22      19      387      292      4       103      25       1,516
           Ovary              1                                             15      329      15      22      130      269      8       51       13       853
           Kidney             0                                             1       6        1       2       5        13       1       3        4        35
           Bladder            0                                             3       35       1       3       24       19       1       10       2        98
           Total              9                                             284     2,737    242     244     2,622    2,528    146     1386     642      10,840
  Total                       38                                            1,535   26,815   1,187   3,599   10,718   13,716   1,305   16,121   19,279   94,312

*Selection of smoking-related cancer*

According to the level of evidences, we decided to include fourteen types of cancer with positive association with tobacco smoking shown by relative risk (RR) value more than one in this analysis, provided by Kristina et al., (2016) study. The cancer included cancer of lip and oral cavity (C00-08), nasopharynx (C11), others pharynx (C09--10,C12--14), esophagus (C15), stomach (C16), colorectal (C18--20), liver (C22), pancreas (C25), larynx (C32), lung cancer (C33--34), cervix uteri (C53), ovary (C56), kidney (C64--66), and urinary bladder (C67). Most RR of tobacco smoking-related cancer were in that study derived from recent meta-analysis (Gandini et al., 2008), which consisted of 254 reports, of which 8 were from Africa, 28 were from Japan, 8 were from India, 39 were from China, 13 were from South America, and the others were from western countries (Kristina et al., 2016). That global meta-analysis was selected because it is the most updated and there is no many meta-analysis conducted in Asia exists.

*Incidence and cancer mortality*

The number of cancer incidence and mortality in ASEAN member countries in 2018 were derived from GLOBOCAN 2018. GLOBOCAN is an online database from WHO International Agency for Research on Cancer (IARC) that providing estimates of incidence and mortality in 185 countries for 36 types of cancer (International Agency for Research on Cancer (IARC), 2012). The methods of estimation are country specific and the quality of the estimation depends upon the quality and on the amount of the information available for each country. Incidence data are derived from national cancer registries (Bray et al., 2018). If country data is not available, estimation by modeling, using incidence mortality ratios derived from recorded data in country or local cancer registries is used. Mortality statistics were based on national data that are collated and made available by the WHO for countries with vital registration (Bray et al., 2018). Incidence and mortality from ten countries in Southeast Asia region were available, while Timor Leste data was not available yet for incidence and mortality of cancers in 2018.

*Estimation of smoking attributable fraction (SAF) of cancer*

To calculate SAF values due to cancer, two parameters were considered: 1) the relative risks of tobacco smoking for the different related cancer, and 2) prevalence of smokers for male and female. The formula of SAF is shown below,

$\mathit{SAF}_{s} = \frac{p\left( \mathit{PRi} - 1 \right)}{1 + p\left( \mathit{rri} - 1 \right)}$

where "p" is the prevalence of smokers in the national population, "RR" is the relative risk of illness due to tobacco smoking, sub-script-i is a category of disease. Exception for Singapore, due to there has been no any prevalence data of tobacco smoking, the SAF value gained and used directly from prevalence-based study of Gandini et al., (2008).

Results
=======

Relative risks and SAF of countries members of ASEAN reported in [Table 2](#T2){ref-type="table"}. As the strongest association with smoking was found for lung cancer (World Health Organization (WHO), 2011b), tobacco smoking is attributable to about 3% - 89.6% for male population in ASEAN member countries. Meanwhile for female, tobacco smoking is attributable to lung cancer about 11% - 89.6%.

Furthermore, smoking attributable cancer incidence in ASEAN member countries has shown in [Table 3](#T3){ref-type="table"}. According to the estimation, tobacco smoking accounted for 121,849 new cancer cases in 2018 (106,858 male and 14,991 female cases). In male, the total number of tobacco smoking attributable cancer incidence was the highest in Indonesia (32,585), followed by Viet Nam (23,363 cases), and Thailand (16,953 cases). On the other hand, the three highest number of tobacco smoking attributable cancer incidence in female was found in Indonesia (4,293 cases), Philippines (3,673) and Myanmar (3,299 cases). In male, the number of patients with lung cancer (50,016) attributable to tobacco smoking was the highest followed by liver cancer (12,363) and nasopharynx cancer (8,087). Meanwhile, in female, the number of patients with lung cancer (7,076) attributable to tobacco smoking was also the highest followed by cervix uteri cancer (2,819) and ovary cancer (1,513).

On the other hand, total cancer mortality in ASEAN due to tobacco smoking accounted for 94,312 which consisted of 83,472 and 10,840 cancer mortality for male and female respectively as shown in [Table 4](#T4){ref-type="table"}. Same as cancer incidence in male, the total number of smoking attributable cancer mortality was the highest in Indonesia (24,077), followed by Viet Nam (18,637), and Thailand (14,735). On the other hand, the three highest number of smoking attributable cancer mortality in female was found in Indonesia (2,737), Myanmar (2,622), and Philippines (2,528). In male, the number of patients with lung cancer mortality attributable to tobacco smoking was the highest (44,896) followed by liver cancer (12,363), and nasopharynx (5,167). Same as in male, for female, the number of patients with lung cancer mortality attributable to smoking was the highest (6,197), followed by cervix uteri (1,516) and ovary (853).

Discussion
==========

It is clear that cancer is an urgent global challenge that need prevention, early detection and diagnosis, treatment, and care services. Meanwhile tobacco consumption also remains a significant threat to public health and associated with different types of cancer (Bassiony et al., 2015; Islami et al., 2015). This study found that tobacco smoking was responsible for 121,849 new cancer cases in 2018 (106,858 male and 14,991 female cases) in ASEAN 2018. Our findings are slightly lower than previous study in 2012, with total of new cancer cases was 131,502 (114,775 cancer incidence in male and 16,727 in female, higher than in 2018, both for male and female (Kristina et al., 2016).

On the other hand, the comparison of cancer mortality due to tobacco smoking of male between data from 2012 and 2018 is shown in Figure 1. From the figure, it can be seen that the cancer mortality was mostly lower in 2018 than 2012 for bladder, kidney, lung, pancreas, liver, colorectal, stomach, esophagus, pharynx and lip, oral cavity cancer. Only larynx and nasopharynx cancer have had higher number of mortality in 2012 than 2018. In addition, for female, cancer mortality was also mostly lower in 2018 than 2012 in bladder, kidney, lung, larynx, pancreas, liver, colorectal, stomach, esophagus, pharynx, lip, oral cavity cancer. Only female mortality of ovary, cervix uteri and nasopharynx cancer in 2018 were higher than 2012.

Incidence data are produced by population based cancer registries. According to recent data compiled in Volume XI of the IARC's Cancer Incidence in Five Continents, approximately 15% of the world population was covered by high-quality cancer registries around 2010, with lower registration in Asia only 6.5% of the total population (Bray et al., 2018). As well as for number of mortality, the recorded data from lower resource countries are the only relatively unbiased source of information on the distribution of common cancer types in a defined population. Lower number of cancer incidence and mortality between 2018 and 2012 in member countries of ASEAN may drive by different number cancer registries in those years.

In addition, contemporary information on the fraction of cancer that potentially could be prevented, like tobacco smoking, is useful for priority setting in cancer prevention and control (Islami et al., 2018). For many years, WHO has worked with governments worldwide to strengthen policies, programs and strategies that prevent and reduce tobacco use, like MPOWER which measures assist in reducing the demand for tobacco products at country-level (Singh, 2012; World Health Organization (WHO), 2013). Global experiences have revealed prevalence of tobacco smoking can effectively decrease with implementation of MPOWER policies (Malhi et al., 2015 ; Heydari et al., 2016; Kumar and Purushothama, 2018). More member countries of ASEAN are showing leadership in adopting effective policies in the MPOWER suite of interventions such as raising taxes on tobacco, establishing smoke-free areas and implementing graphic health warnings (Amul and Pang, 2017).

Report tracks implementation progress of tobacco tax policy against the WHO Framework convention on tobacco Control (FCTC) in 10 ASEAN countries (WHO, 2011). Southeast Asia tobacco Control Alliance (SEATCA) believes that better health of the population as result of higher excise taxes on tobacco will lead to better labor productivity, speedier economic development and to less suffering in the region (Southeast Asia tobacco Control Alliance (SEATCA), 2017). Evidence from India and Bangladesh suggested that taxation had significantly reduced tobacco use among adults (John et al., 2018). Price policies involving taxation have been also used to control smoking not only in Thailand but also in other countries around the world. In Thailand, consumption of Tobacco products was found to have decreased (Gupta et al., 2016) relatively continuous in relation to that of other goods (World Health Organisation (WHO), 2011). Price policies through taxation to combat smoking have been very active over the period after 1996 in Thailand, consequently, Tobacco products have become relatively more expensive (Sarntisart, 2011).

In addition, communicating the health effects of smoking using vivid, large and prominent pictorial health warnings (PHWs) on Tobacco packages remains a primary goal of national Tobacco control policy. From a public health perspective, Tobacco packaging serves as the most cost effective communications channel for governments to convey the health risks of Tobacco use, especially among those with low literacy levels. To date, more than 80 countries and territories across the globe, including ten ASEAN countries, have analyzed PHW requirements in accordance to WHO FCTC. South East Asia is only region in the world where all its countries implemented PHWs on Tobacco packages (Tan, 2016) and constantly put efforts into the Tobacco control field with high commitment from the government, scientists and activists through MPOWER implementation (Minh et al., 2016).

Therefore, ASEAN member countries are strongly encouraged to strengthen the existing Tobacco control (Centers for Disease Control and Prevention (CDC), 2012) measure in order to effectively gain a significant decline of Tobacco smoking related cancer in the future. ASEAN member countries need to further invest and innovate on Tobacco control and promoting healthy lifestyles to achieve the target on decrease number of cancer attributable Tobacco smoking. However, the study results may underestimate the overall proportion of cancer incidence and mortality attributable to Tobacco smoking, because many others risk factors associated with cancer such as diet, body mass index (BMI), and alcohol consumption (Peppone et al., 2009; Peppone et al., 2010) are not included in the research model and thus have the potential to cause bias. Furthermore, due to substantial economic development in ASEAN might be changed dramatically so that the SAF may need to be re-estimated in order to gain more accurate estimation.

This study found that Tobacco smoking was responsible for 121,849 new cancer cases in 2018 (106,858 male and 14,991 female cases) in ASEAN 2018. Our findings are mostly lower than previous study in 2012, both for cancer incidence and mortality in male and female. More ASEAN member states are showing leadership in adopting effective policies in the MPOWER suite of interventions such as raising taxes on Tobacco, establishing smoke-free areas and implementing graphic health warnings. Therefore, ASEAN member countries are strongly encouraged to put in place stronger Tobacco control policies and to strengthen the existing Tobacco control measure in order to effectively control cancer in the future.
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